Reni Benjamin
Stock Analyst at Citizens JMP
(0.05)
# 4,357
Out of 4,382 analysts
816
Total ratings
33.4%
Success rate
-10.1%
Average return
Main Sectors:
Stocks Rated by Reni Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Maintained: Buy | $35 → $41 | $26.09 | +57.15% | 47 | Apr 23, 2026 | |
| WHWK Whitehawk Therapeutics | Initiated Coverage: Buy | $8 | $4.15 | +92.77% | 1 | Apr 16, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | $5 → $8 | $1.88 | +325.53% | 36 | Apr 14, 2026 | |
| BCYC Bicycle Therapeutics | Maintained: Buy | $12 → $8 | $4.19 | +90.93% | 37 | Mar 18, 2026 | |
| IMMP Immutep | Downgraded: Hold | n/a | $0.3766 | - | 2 | Mar 13, 2026 | |
| PRLD Prelude Therapeutics | Maintained: Buy | $3 → $6 | $3.81 | +57.48% | 15 | Mar 11, 2026 | |
| LYEL Lyell Immunopharma | Initiated Coverage: Buy | $34 | $11.97 | +184.04% | 1 | Mar 9, 2026 | |
| IMMX Immix Biopharma | Initiated Coverage: Buy | $23 | $7.93 | +190.04% | 1 | Mar 9, 2026 | |
| IOVA Iovance Biotherapeutics | Upgraded: Buy | $5 | $4.23 | +18.20% | 49 | Feb 25, 2026 | |
| BCAX Bicara Therapeutics | Initiated Coverage: Buy | $31 | $20.00 | +55.00% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.3923 | - | 12 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $24.04 | +33.11% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.04 | +390.20% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $348 → $396 | $270.10 | +46.61% | 10 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $8 | $2.68 | +198.51% | 16 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.26 | - | 28 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $8.74 | +174.60% | 41 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $102.38 | - | 105 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.33 | - | 23 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $14.77 | +170.82% | 8 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.07 | - | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $87.01 | n/a | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $29.46 | n/a | 27 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.10 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.95 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.71 | n/a | 20 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $6 | $0.0339 | n/a | 19 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.92 | n/a | 24 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $56.77 | n/a | 1 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $5 | $1.19 | n/a | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $57 | $26.85 | n/a | 14 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 → $94 | $6.08 | n/a | 12 | Feb 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $0.9353 | n/a | 4 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5 | $2.28 | n/a | 25 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $3.33 | n/a | 9 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $10 | $7.97 | n/a | 17 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $13 | $0.5188 | n/a | 16 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $40.16 | n/a | 25 | Aug 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.20 | n/a | 8 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.98 | n/a | 21 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.92 | n/a | 14 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.23 | n/a | 10 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0475 | n/a | 7 | Jun 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0014 | n/a | 1 | May 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.06 | n/a | 7 | May 21, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 5 | May 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $3.09 | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $1.06 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $12 | $26.71 | n/a | 7 | Mar 19, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.36 | n/a | 4 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.23 | n/a | 6 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $0.000001 | n/a | 6 | Dec 11, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.74 | n/a | 3 | Oct 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $35.56 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 | $15.75 | n/a | 1 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.17 | n/a | 2 | Oct 12, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.56 | n/a | 2 | May 10, 2010 |
Sutro Biopharma
Apr 23, 2026
Maintained: Buy
Price Target: $35 → $41
Current: $26.09
Upside: +57.15%
Whitehawk Therapeutics
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $4.15
Upside: +92.77%
Allogene Therapeutics
Apr 14, 2026
Maintained: Buy
Price Target: $5 → $8
Current: $1.88
Upside: +325.53%
Bicycle Therapeutics
Mar 18, 2026
Maintained: Buy
Price Target: $12 → $8
Current: $4.19
Upside: +90.93%
Immutep
Mar 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.3766
Upside: -
Prelude Therapeutics
Mar 11, 2026
Maintained: Buy
Price Target: $3 → $6
Current: $3.81
Upside: +57.48%
Lyell Immunopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $11.97
Upside: +184.04%
Immix Biopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $7.93
Upside: +190.04%
Iovance Biotherapeutics
Feb 25, 2026
Upgraded: Buy
Price Target: $5
Current: $4.23
Upside: +18.20%
Bicara Therapeutics
Jan 29, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $20.00
Upside: +55.00%
Dec 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.3923
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $24.04
Upside: +33.11%
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $2.04
Upside: +390.20%
Nov 7, 2025
Maintained: Buy
Price Target: $348 → $396
Current: $270.10
Upside: +46.61%
Oct 30, 2025
Maintained: Buy
Price Target: $5 → $8
Current: $2.68
Upside: +198.51%
Oct 8, 2025
Reiterated: Hold
Price Target: n/a
Current: $7.26
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: $24
Current: $8.74
Upside: +174.60%
Sep 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $102.38
Upside: -
Sep 9, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.33
Upside: -
Sep 8, 2025
Reiterated: Buy
Price Target: $40
Current: $14.77
Upside: +170.82%
Aug 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.07
Upside: -
May 15, 2025
Maintained: Hold
Price Target: n/a
Current: $87.01
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: $2
Current: $29.46
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $2.10
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $2.95
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
May 10, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.71
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $16 → $6
Current: $0.0339
Upside: n/a
May 2, 2019
Maintained: Hold
Price Target: n/a
Current: $3.92
Upside: n/a
Apr 9, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $56.77
Upside: n/a
Mar 18, 2019
Maintained: Buy
Price Target: $6 → $5
Current: $1.19
Upside: n/a
Mar 1, 2019
Maintained: Buy
Price Target: $73 → $57
Current: $26.85
Upside: n/a
Feb 5, 2019
Upgraded: Buy
Price Target: $96 → $94
Current: $6.08
Upside: n/a
Dec 13, 2018
Maintained: Buy
Price Target: $21
Current: $0.9353
Upside: n/a
Nov 15, 2018
Upgraded: Buy
Price Target: $5
Current: $2.28
Upside: n/a
Nov 14, 2018
Upgraded: Buy
Price Target: n/a
Current: $3.33
Upside: n/a
Oct 12, 2018
Maintained: Buy
Price Target: $11 → $10
Current: $7.97
Upside: n/a
Aug 28, 2018
Maintained: Buy
Price Target: $13 → $13
Current: $0.5188
Upside: n/a
Aug 14, 2018
Maintained: Buy
Price Target: $22
Current: $40.16
Upside: n/a
Aug 10, 2018
Maintained: Hold
Price Target: n/a
Current: $1.20
Upside: n/a
Aug 7, 2018
Maintained: Hold
Price Target: n/a
Current: $1.98
Upside: n/a
Aug 7, 2018
Maintained: Hold
Price Target: n/a
Current: $6.92
Upside: n/a
Dec 18, 2017
Rated: Hold
Price Target: n/a
Current: $8.23
Upside: n/a
Jun 4, 2015
Reiterated: Buy
Price Target: $6
Current: $0.0475
Upside: n/a
May 26, 2015
Initiated Coverage: Buy
Price Target: $13
Current: $0.0014
Upside: n/a
May 21, 2015
Maintained: Buy
Price Target: $8
Current: $2.06
Upside: n/a
May 15, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $7 → $3
Current: $3.09
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $9 → $5
Current: $1.06
Upside: n/a
Mar 19, 2015
Reiterated: Buy
Price Target: $8 → $12
Current: $26.71
Upside: n/a
Feb 18, 2015
Reiterated: Buy
Price Target: $4
Current: $2.36
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $6
Current: $3.23
Upside: n/a
Dec 11, 2014
Maintained: Buy
Price Target: $40
Current: $0.000001
Upside: n/a
Oct 13, 2014
Maintained: Hold
Price Target: n/a
Current: $1.74
Upside: n/a
May 5, 2014
Initiated Coverage: Buy
Price Target: $17
Current: $35.56
Upside: n/a
Jul 24, 2013
Downgraded: Hold
Price Target: $39
Current: $15.75
Upside: n/a
Oct 12, 2010
Reiterated: Buy
Price Target: $9
Current: $1.17
Upside: n/a
May 10, 2010
Reiterated: Buy
Price Target: n/a
Current: $2.56
Upside: n/a